Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Biljana, Dumevska"'
Autor:
Leslie Caron, Devaki Kher, Kian Leong Lee, Robert McKernan, Biljana Dumevska, Alejandro Hidalgo, Jia Li, Henry Yang, Heather Main, Giulia Ferri, Lisa M. Petek, Lorenz Poellinger, Daniel G. Miller, Davide Gabellini, Uli Schmidt
Publikováno v:
Stem Cells Translational Medicine, Vol 5, Iss 9, Pp 1145-1161 (2016)
Facioscapulohumeral muscular dystrophy (FSHD) represents a major unmet clinical need arising from the progressive weakness and atrophy of skeletal muscles. The dearth of adequate experimental models has severely hampered our understanding of the dise
Externí odkaz:
https://doaj.org/article/acc0cb4ac8ae47ce9836e621e6d06fb8
Publikováno v:
Stem Cell Research, Vol 16, Iss 2, Pp 430-433 (2016)
The Genea020 human embryonic stem cell line was derived from a donated, fully commercially consented ART blastocyst, carrying Htt gene CAG expansion of 48 repeats, indicative of Huntington disease. Following ICM outgrowth on inactivated human feeders
Externí odkaz:
https://doaj.org/article/e6421b30a4934351a06a5a9430c292d1
Publikováno v:
Stem Cell Research, Vol 16, Iss 2, Pp 503-506 (2016)
The Genea050 human embryonic stem cell line was derived from a donated, fully commercially consented ART blastocyst, carrying a deletion in 4q35 with only 5 D4Z4 repeats by PGD linkage analysis, indicative of FSHD1. Following ICM outgrowth on inactiv
Externí odkaz:
https://doaj.org/article/342fc31674dd40408befaa2514e1d371
Publikováno v:
Stem Cell Research, Vol 16, Iss 2, Pp 327-330 (2016)
The Genea052 human embryonic stem cell line was derived from a donated, fully commercially consented ART blastocyst, through ICM outgrowth on inactivated human feeders. The line showed pluripotent cell morphology and genomic analysis verified a 46, X
Externí odkaz:
https://doaj.org/article/7c4ebab6676c44fcaf642171b78ccf42
Publikováno v:
Stem Cell Research, Vol 16, Iss 2, Pp 456-459 (2016)
The Genea023 human embryonic stem cell line was derived from a donated, fully commercially consented ART blastocyst, through ICM outgrowth on inactivated feeders. The line showed pluripotent cell morphology and genomic analysis verified a 46, XY kary
Externí odkaz:
https://doaj.org/article/a3993e3f00474ce5812423ec8c92fa1e
Publikováno v:
Stem Cell Research, Vol 16, Iss 2, Pp 401-404 (2016)
The Genea021 human embryonic stem cell line was derived from a donated, fully commercially consented ART blastocyst, carrying Trisomy 21, indicative of Down Syndrome. Following ICM outgrowth on inactivated human feeders, CGH and STR analyses demonstr
Externí odkaz:
https://doaj.org/article/3bf7e784d7cd42a694c2453e19c44a0d
Publikováno v:
Stem Cell Research, Vol 16, Iss 2, Pp 437-439 (2016)
The Genea067 human embryonic stem cell line was derived from a donated, fully commercially consented ART blastocyst, carrying expansion of CTG repeats in the DMPK gene, indicative of Myotonic Dystrophy Type 1 (DM1). Following ICM outgrowth on inactiv
Externí odkaz:
https://doaj.org/article/a02f4eaadf8e4f108694275e53840837
Publikováno v:
Stem Cell Research, Vol 16, Iss 2, Pp 440-442 (2016)
The Genea079 human embryonic stem cell line was derived from a donated, fully commercially consented ART blastocyst, carrying compound heterozygous mutations in the NEB gene, exon 55 deletion & c.15110dupA, indicative of Nemaline Myopathy Type 2 (NEM
Externí odkaz:
https://doaj.org/article/0eb9aea07dbf492eab908ebacc478039
Autor:
Nadine Azzam, Nicole Melong, Lissandra Tuzi, Lisa Pinto, Jamie I. Fletcher, Alvin Kamili, Biljana Dumevska, Loretta Lau, Jennifer A. Chan, Donna L. Senger, Stephanie A. Grover, Michelle Haber, David Malkin, Jason N. Berman
Publikováno v:
Cancer Research. 83:4670-4670
There has been dramatic improvement in treatment outcomes for many pediatric cancers over the last three decades. However, for the 20% of young people with relapsed or refractory cancer, the prognosis remains grim. Canada’s PRecision Oncology For Y
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b695ae8960b7e1201b94600690dcd2f
https://doi.org/10.1158/1538-7445.am2023-4670
https://doi.org/10.1158/1538-7445.am2023-4670
Autor:
Claire Xin Sun, Paul Daniel, Gabrielle Bradshaw, Hui Shi, Melissa Loi, Nicole Chew, Sarah Parackal, Vanessa Tsui, Yuqing Liang, Mateusz Koptyra, Shazia Adjumain, Christie Sun, Wai Chin Chong, Dasun Fernando, Caroline Drinkwater, Motahhareh Tourchi, Dilru Habarakada, Dhanya Sooraj, Diana Carvalho, Phillip B. Storm, Valerie Baubet, Leanne C. Sayles, Elisabet Fernandez, Thy Nguyen, Mia Pörksen, Anh Doan, Duncan E. Crombie, Monty Panday, Nataliya Zhukova, Matthew D. Dun, Louise E. Ludlow, Bryan Day, Brett W. Stringer, Naama Neeman, Jeffrey A. Rubens, Eric H. Raabe, Maria Vinci, Vanessa Tyrrell, Jamie I. Fletcher, Paul G. Ekert, Biljana Dumevska, David S. Ziegler, Maria Tsoli, Nur Farhana Syed Sulaiman, Amos Hong Pheng Loh, Sharon Yin Yee Low, E. Alejandro Sweet-Cordero, Michelle Monje, Adam Resnick, Chris Jones, Peter Downie, Bryan Williams, Joseph Rosenbluh, Daniel Gough, Jason E. Cain, Ron Firestein
Publikováno v:
Cancer Cell. 41:660-677.e7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b51249b39ecfa0cd01cfc99d21fb6b2a
https://doi.org/10.1016/j.ccell.2023.03.007
https://doi.org/10.1016/j.ccell.2023.03.007